Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Finding history
Finding company history timeline
George Rathmann in one of the Building 2 laboratory bays in 1982.
Led by CFO Gordon Binder, Amgen’s IPO on June 17, 1983, raises nearly $40 million.
Staff numbers reach 3,396 globally, up from only 344 when Binder was named CEO in 1988.
On February 21, 1991, NEUPOGEN® (filgrastim) is approved by the FDA.
On January 2, 1992, Amgen is added to the S&P 500 and months later, the Company debuts on the Fortune 500 list.
Vice President Al Gore presents the 1994 National Medal of Technology to CEO Gordon Binder.
Kevin Sharer and Amgen’s executive management team were featured in the July 2001 Pharmaceutical Executive magazine—the top trade journal in the industry.
On January 31, 2002, Neulasta® (pegfilgrastim) is approved by the FDA.
On September 27, 2006, Vectibix® (panitumumab) is approved by the FDA
Prolia® (denosumab) and XGEVA® (denosumab) are approved by the FDA on June 1, 2010 and November 18, 2010, respectively.
On August 27, 2015, Repatha® (evolocumab) is approved by the FDA.
On September 23, 2016, AMJEVITA™ (Adalimumab-Atto) is approved by the FDA. It is Amgen's first biosimilar to receive regulatory approval.
© 2016 by Myron Toback Inc.
On November 21, 2019, Amgen completes the acquisition of Otezla® (apremilast).
On August 24, 2020, Amgen joins the Dow Jones Industrial Average.
Rate how well Finding lives up to its initial vision.
Finding jobs
Do you work at Finding?
Is Finding's vision a big part of strategic planning?
Finding competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Baltz & Company | 1998 | $1.2M | 19 | - |
| Venue Management Systems | 1985 | $180.0M | 3,300 | - |
| Aperture | 1952 | $10.0M | 30 | 1 |
| Asb | - | $1.1B | 4,907 | 4 |
| American Angus Association | - | $50.0M | 532 | 7 |
| P-B-L | 1975 | $410,000 | 5 | - |
| Blue Planet | 2006 | $400,000 | 10 | - |
| Jharkhand High Court - India | 2000 | $230.0M | 10,001 | - |
| DNM | 2002 | $1.6M | 30 | - |
| AIN | 1986 | $910,000 | 15 | - |
Finding history FAQs
Zippia gives an in-depth look into the details of Finding, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Finding. The employee data is based on information from people who have self-reported their past or current employments at Finding. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Finding. The data presented on this page does not represent the view of Finding and its employees or that of Zippia.
Finding may also be known as or be related to Finding, Findings, Findings, Inc. and Findings, Incorporated.